Sort
261,768 grants matching “gene therapy”
Molecular Therapeutics for Anaplastic Gliomas
$1,073,000G. Yancey Gillespie · University Of Alabama At Birmingham · P50 · FY2007 · CA
Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage
$1,072,951Jeffery J Auletta · National Marrow Donor Program · U01 · FY2024 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,072,901Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for
$1,072,868V Michael Holers · University Of Colorado Denver · U01 · FY2014 · AI
De facto monotherapy during multidrug TB treatment and emergence of resistance
$1,072,858Veronique Dartois · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Development of a drug discovery platform for human islets
$1,072,731Benjamin M Buehrer · Zen-Bio, Inc. · R44 · FY2014 · DK
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,072,693Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia
$1,072,629Ronald Lee Anderson · Rithim Biologics, Inc. · R44 · FY2025 · HL
Maintenance of Models of Human Hemophilia and VWD
$1,072,618Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2017 · HL
Maintenance of Models of Human Hemophilia and VWD
$1,072,618Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2015 · HL
Structural studies of molecular targets for drug development
$1,072,564David S Waugh · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Dynamic regulatory network models of human response to influenza virus
$1,072,559Ivan Marazzi · University Of California-Irvine · U01 · FY2023 · AI
Nutrition Obesity Research Center (NORC)
$1,072,551Elizabeth J Mayer-Davis · Univ Of North Carolina Chapel Hill · P30 · FY2025 · DK
Cardiovascular potassium channels: From molecular basis to disease therapeutics
$1,072,401Colin G Nichols · Washington University · R35 · FY2025 · HL
Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer
$1,072,330Christian Shenouda · Immunicom, Inc. · R44 · FY2022 · CA
Walking forward - American Indian Participation in Cancer Clinical Trials
$1,072,142Daniel G Petereit · Rapid City Regional Hospital · U54 · FY2011 · CA
Tissue injury and inflammation in MS (P50)
$1,072,061Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · P50 · FY2012 · NS
Protein Modifications Involved in Cell Signaling
$1,072,043Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development of New Hypoxic Cytotoxins for Cancer Therapy
$1,072,008John Martin Brown · Stanford University · P01 · FY2008 · CA
Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease
$1,071,897David Radin · Biostrategies, Lc · R44 · FY2018 · NS
Retinal Gene Therapy
$1,071,862Peter Colosi · National Eye Institute · ZIA · FY2009 · EY
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,071,845Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$1,071,845Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
International Tuberculosis Clinical Research
$1,071,829Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
The Unfolded Protein Response in Cancer
$1,071,768Constantinos Koumenis · University Of Pennsylvania · P01 · FY2017 · CA